L'intérêt à découvert pour Tempus AI donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Tempus AI. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Tempus AI (NASDAQ:TEM) Stock, Rapport sur les intérêts à découvert

Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Tempus AI Inc

TEMCO

J.P. Morgan Exchange-Traded Fund Trust JPMorgan Climate Change Solutions ETF

PERSOL HLDG CO LTD ORD by Persol Holdings Co Ltd

Persol Holdings Co Ltd

TEMPLE BAR INVST TR NEW by Temple Bar Investment Trust Plc

TEMPLETON EMRGNG MKT NEW by Templeton Emerging Markets Trust

TEMPUS HLDGS LTD by TEMPUS HLDGS LTD.

Tema ETF Trust Global Royalties ETF

Tema ETF Trust Tema American Reshoring ETF

Tema ETF Trust Tema Luxury ETF

Tema ETF Trust Tema Monopolies and Oligopolies ETF

Tema Electrification ETF

Tema GLP-1, Obesity & Cardiometabolic ETF

Tema Neuroscience and Mental Health ETF

Tema Oncology ETF

TEMAS RESOURCES CORP by Temas Resources Corp.

Temas Resources Corp

Temas Resources Corp Ordinary Shares

TEMECULA VALLEY BNCRP INC by Temecula Valley Bancorp, Inc.

Temecula Valley Bancorp Inc

Temenos AG

Temir Corp

Tempest Therapeutics, Inc. - Common Stock

Tempest Therapeutics Inc

TEMPLE & WEBSTER GRP ORD by Temple & Webster Group Ltd.

Temple & Webster Group Ltd

Templeton Dragon Fund Inc

Templeton Emerging Markets Fund Common Stock

Templeton Emerging Markets Fund

Templeton Emerging Markets Income Fund, Inc. Common Stock

Templeton Emerging Markets Income Fund

Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest

Templeton Global Income Fund

Tempo Automation Holdings Inc

TEMPO AUTOMATION HLDGS by Tempo Automation Holdings, Inc.

Tempo Automation Holdings Inc Warrants (22/11/2027)

Tempur Sealy International, Inc. Common Stock

Tempur Sealy International Inc

Macro Economic Events

Macro Notification

Market Summary

Forex

Economics

Markets

General

IONQ

RGTI

SPOT

Benzinga Market Summary: Quantum Stocks Slide On NVIDIA CEO Huang's Comments On Sector, Goldman Upgrades Spotify, US Dollar Index rises

It wasn't just the CES 2025 buzz that rattled quantum stocks this week — a dose of cold water came from none other than Nvidia Corp&#8216;s CEO Jensen Huang.
Speaking at Nvidia&#8217;s Analyst Day, Huang made it <a href="https://www.benzinga.com/25/01/42878295/quantum-stocks-tumble-why-rigetti-ionq-and-d-wave-are-falling" target="_blank" rel="noreferrer noopener">clear</a>: &#8220;very useful&#8221; quantum computers are likely decades away. In fact, he pegged the most optimistic timeline for a breakthrough in 15 to 20 years, with 30 years perhaps being more realistic. The comments have sent shockwaves through the quantum computing space, where stocks had been soaring on speculation about the technology&#8217;s potential.
Shares of key players like IonQ Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>), Rigetti Computing Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>), and D-Wave Quantum Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) took a hit, plunging by as much as 40% in just a few days. While these stocks had been riding high on massive gains over the past year — with IonQ up a jaw-dropping 129% and Rigetti seeing an 828% surge — the CEO's reality check has sparked a sharp reversal.
Read Also: <a href="https://www.benzinga.com/news/small-cap/24/12/42700917/3-russell-2000-tech-stocks-skyrocketed-1000-more-2024-analysts-getting-started">3 Russell 2000 Tech Stocks That Skyrocketed 1,000% Or More In 2024: Analysts Say They&#8217;re Just Getting Started</a>
Let&#8217;s dive into the numbers and technicals:
<h2 class="wp-block-heading">IonQ</h2>
IonQ&#8217;s shares are feeling the burn after the CEO's comments, down nearly 30% over the past five days. However, with the stock hovering just above key moving averages, there are still glimmers of hope. 
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent010825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="627" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08105144/Screenshot-2025-01-08-at-9.20.42-PM.png" alt="" class="wp-image-724329" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08105144/Screenshot-2025-01-08-at-9.20.42-PM.png 627w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08105144/Screenshot-2025-01-08-at-9.20.42-PM-300x234.png 300w" sizes="(max-width: 627px) 100vw, 627px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent010825&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
Its eight-day simple moving average (SMA) of $43.76 suggests it could be primed for a bounce, while the 200-day SMA at $14.33 is also showing a solid bullish signal. 
But, the technicals paint a mixed picture – the stock is under heavy selling pressure and is below its eight, 20, and 50-day SMAs. The risk of further bearish movement remains, but the relative strength index (RSI) of 39.05 shows it&#8217;s not quite oversold yet.
<h2 class="wp-block-heading">Rigetti Computing</h2>
Rigetti&#8217;s shares have been hit by the quantum frost, down 35% in the last five days. Yet, the company still carries strong technicals. 
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent010825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="627" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08105155/Screenshot-2025-01-08-at-9.20.53-PM.png" alt="" class="wp-image-724330" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08105155/Screenshot-2025-01-08-at-9.20.53-PM.png 627w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08105155/Screenshot-2025-01-08-at-9.20.53-PM-300x234.png 300w" sizes="(max-width: 627px) 100vw, 627px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent010825&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
The eight-day SMA of $16.98 and the 20-day SMA of $12.39 both point to a potential rebound. The RSI is neutral at 46.58, and moving average convergence/divergence (MACD) indicator is bullish at 3.22. If the quantum sector catches a break, Rigetti might be one to watch.
<h2 class="wp-block-heading">D-Wave Quantum</h2>
D-Wave Quantum has been one of the hardest hit, with a 40% drop in just a few days. Still, its technical indicators remain resilient.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent010825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="627" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08105206/Screenshot-2025-01-08-at-9.21.02-PM.png" alt="" class="wp-image-724332" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08105206/Screenshot-2025-01-08-at-9.21.02-PM.png 627w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08105206/Screenshot-2025-01-08-at-9.21.02-PM-300x234.png 300w" sizes="(max-width: 627px) 100vw, 627px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent010825&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
The eight-day SMA of $8.88 and the 20-day SMA of $7.61 show strong bullish signals, but D-Wave is still facing some bearish pressure, being below its recent SMAs. The RSI of 42.88 indicates that the stock is neither oversold nor overbought, suggesting a balance between buying and selling sentiment. MACD is positive and bullish at 1.23 despite the recent slid.
While Huang's comments have thrown a wrench in the momentum for these quantum darlings, the technicals don't entirely rule them out as potential buys, especially if the broader market sentiment shifts or if progress in quantum computing surprises us.
For now, it's a waiting game. The quantum computing sector might be experiencing a temporary stumble, but if the long-term potential holds up, these stocks could rise again once the storm clears. Time to buckle up and watch this quantum rollercoaster unfold.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/01/42846829/quantum-si-327-rally-in-six-months-is-nvidia-the-catalyst-for-more-gains">Quantum-Si&#8217;s 327% Rally In Six Months: Is Nvidia The Catalyst For More Gains?</a></li>
</ul>
Image: Shutterstock

Technicals

Tech

Trading Ideas

QBTS

Quantum Stocks Face Reality Check After Nvidia CEO's Comments: What Do The Charts Show?

CBRE initiates coverage on Ryman Hospitality Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHP#NYSE">RHP</a>) with a Buy rating and announces Price Target of $130.

News

Price Target

Initiation

Analyst Ratings

CBRE Initiates Coverage On Ryman Hospitality Props with Buy Rating, Announces Price Target of $130

INDA

SMIN

Live On CNBC, Steve Weiss Announces Sold INDA & SMIN India ETFs

U.S. stocks traded slightly lower midway through trading, with the Dow Jones index falling around 0.1% on Wednesday.
The Dow traded down 0.05% to 42,507.21 while the NASDAQ dipped 0.14% to 19,461.93. The S&amp;P 500 also fell, dropping, 0.03% to 5,907.51.
Check This Out: <a href="https://www.benzinga.com/25/01/42839544/wells-fargo-gears-up-for-q4-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts">Wells Fargo Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a>
Leading and Lagging Sectors Materials shares rose by 0.1% on Wednesday.
In trading on Wednesday, utilities shares tumbled by 1%.
Top Headline
U.S. initial jobless claims fell by 10,000 to 201,000 in the week ending Jan. 4, recording the lowest level in eleven months and versus market estimates of 218,000.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Sana Biotechnology, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANA#NASDAQ">SANA</a>) shares shot up 193% to $4.8390 after the company on Tuesday announced clinical trial results from its type 1 diabetes study of islet cell transplantation without immunosuppression.</li>
<li>Shares of Silo Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILO#NASDAQ">SILO</a>)got a boost, surging 141% to $2.6680 after the company announced it was awarded a US patent for its PTSD treatment titled &#8216;Pharmacological Prophylactics Against Stress-Induced Affective Disorders in Females.&#8217;</li>
<li>AngioDynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) shares were also up, gaining 29% to $12.11 after the company reported better-than-expected second-quarter financial results and raised its FY25 adjusted EPS guidance.</li>
</ul>
Equities Trading DOWN
<ul>
<li>DatChat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DATS#NASDAQ">DATS</a>) shares dropped 65% to $3.13 after the company announced the pricing of a $5.1 million registered direct offering priced at-the-market under Nasdaq rules.</li>
<li>Shares of Jasper Therapeutics, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JSPR#NASDAQ">JSPR</a>) were down 59% to $7.26. The company reported preliminary data from its BEACON Phase 1b/2a study.</li>
<li>XTI Aerospace, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTIA#NASDAQ">XTIA</a>) was down, falling 54% to $0.0529. XTI Aerospace priced $20 million offering of 363,636,364 shares of common stock at a price of $0.055 per share.</li>
</ul>
Commodities In commodity news, oil traded down 1% to $73.50 while gold traded up 0.4% at $2,676.80.
Silver traded up 0.5% to $30.850 on Wednesday, while copper rose 1.2% to $4.2475.
Euro zone
European shares were lower today. The eurozone's STOXX 600 declined 0.54%, Germany's DAX 40 fell 0.34% and France's CAC 40 dipped 1.1%. Spain's IBEX 35 Index fell 0.61%, while London's FTSE 100 slipped 0.24%.
Asia Pacific Markets
Asian markets closed mostly lower on Wednesday, with Japan's Nikkei 225 falling 0.26%, China's Shanghai Composite Index gaining 0.02%, Hong Kong's Hang Seng Index declining 0.86% and India's BSE Sensex falling 0.07%.
Economics
<ul>
<li>U.S. private businesses added 122,000 workers to their payrolls in December down from 146,000 in November and versus expectations of 140,000.</li>
<li>U.S. initial jobless claims fell by 10,000 to 201,000 in the week ending Jan. 4, recording the lowest level in eleven months and versus market estimates of 218,000.</li>
<li>The Energy Information Administration said U.S. crude inventories declined by 0.959 million barrels last week, compared to market estimates of a 0.6 million barrel decline</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/01/42873668/jim-cramer-lemonade-is-up-too-much-this-health-care-stock-can-go-lower">Jim Cramer: Lemonade Is &#8216;Up Too Much,&#8217; This Health Care Stock Can Go Lower</a></li>
</ul>

Earnings

Equities

Eurozone

Commodities

Intraday Update

ANGO

DATS

Jasper Therapeutics, Inc. - Class A Common Stock

JSPR

SANA

SILO

XTIA

Crude Oil Down 1%; US Weekly Jobless Claims Decline

Flowers Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLO#NYSE">FLO</a>) shares are trading lower on Wednesday. The company entered into a deal to acquire<a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/n42870798/flowers-foods-inc-to-acquire-simple-mills" rel="noreferrer noopener"> </a><a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/n42870798/flowers-foods-inc-to-acquire-simple-mills" rel="noreferrer noopener">Simple Mills</a><a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/n42870798/flowers-foods-inc-to-acquire-simple-mills" rel="noreferrer noopener"> for $795 million in cash</a>.
Flowers Foods secured a $795 million term loan from the Royal Bank of Canada to finance the acquisition.
Following the transaction, Flowers&#8217; proforma total net debt is expected to be around $1.9 billion, with a net debt-to-EBITDA ratio of 3.1x to 3.3x.
Flowers aims to uphold its balanced capital deployment strategy while maintaining its investment-grade debt rating.
The deal, pending customary regulatory approval, is expected to close in the first quarter of 2025.
Synergies: The acquisition of Simple Mills is expected to be immediately accretive to Flowers Foods&#8217; net sales, adjusted EBITDA growth, and <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">adjusted EBITDA margins on a proforma basis</a>.
The deal is also projected to contribute to Flowers&#8217; earnings per share starting in 2026.
Simple Mills is projected to generate 2024 net sales of $240 million, reflecting a 14% growth compared to the previous year.
This acquisition strengthens Flowers&#8217; presence in the better-for-you and snacking segments, boosting its growth and margin potential.
Once completed, Simple Mills will operate as an independent subsidiary under the leadership of founder and CEO Katlin Smith, continuing operations in Chicago, Illinois, and Mill Valley, California.
Ryals McMullian, chairman and CEO of Flowers Foods said, &#8220;With leading market positions and abundant white space for future growth, Simple Mills perfectly fits our strategy of adding compelling brands in better-for-you segments that complement and diversify our existing portfolio.&#8221;
As of Oct. 5, 2024, cash and cash<a href="https://www.benzinga.com/pressreleases/24/11/n41840173/flowers-foods-inc-reports-third-quarter-2024-results" target="_blank" rel="noreferrer noopener"> equivalents stood at $15.0 million</a>.
Investors can gain exposure to the stock via First Trust Cons. Staples AlphaDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXG#NYSE">FXG</a>) and VictoryShares US Small Cap High Div Volatility Wtd ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSB#NASDAQ">CSB</a>).
FLO Price Action: Flower Foods shares are down 3.04% at $19.48 at publication Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/42879720" target="_blank" rel="noreferrer noopener">MicroStrategy Launches Sovereign European Cloud With STACKIT: Details</a></li>
</ul>
Photo: T. Schneider via Shutterstock

Mid Cap

Global

Movers

Flowers Foods Expands Snacking Segment With $795 Million Simple Mills Acquisition

WIIM

CMPX

Compass Therapeutics shares are trading higher after the company announced the advancement of a new drug candidate and updates on other existing studies.

<a href="https://www.bloomberg.com/news/articles/2025-01-08/blackrock-to-cut-about-1-of-its-employees-staff-memo-says?srnd=homepage-americas">https://www.bloomberg.com/news/articles/2025-01-08/blackrock-to-cut-about-1-of-its-employees-staff-memo-says?srnd=homepage-americas</a>
&nbsp;
BlackRock Inc. told employees it's cutting roughly 1% of its workforce after it committed more than $25 billion on acquisitions last year to expand its reach in private-market assets and data.

Management

'BlackRock to Cut About 1% of Its Employees, Staff Memo Says' - Bloomberg News

Economist and prominent macro trader Alex Krüger shared his outlook on Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) trajectory and market dynamics for 2025, emphasizing the potential for short-term trading opportunities as <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42878139/peter-schiff-doesnt-hate-bitcoin-but-warns-millions-will-lose-more-than-they-can-afford-in-speculative-mania">macroeconomic conditions evolve</a>.  
What Happened: In several <a href="https://x.com/krugermacro/status/1876820416578076998">posts</a> on X, Krüger highlighted a key shift in market expectations over the past weeks:
<ul>
<li>Three months ago, markets were pricing in seven 25-basis-point rate cuts by the end of 2025. Now, that number has dropped to two or fewer cuts, reflecting a more conservative monetary policy outlook.</li>
<li>This shift supports a bullish case for equities in Q1, with Bitcoin expected to mirror the trend.</li>
</ul>
However, Krüger noted the days of &#8220;easy money&#8221; appear to be over. The macro environment is becoming less conducive to passive strategies, with 2025 poised to reward active and short-term traders. 
This is unlike the holding strategy that worked best in 2023-2024, when ignoring macro trends was often optimal.
Altcoin Sensitivity:
Krüger pointed out that altcoins are especially vulnerable to Bitcoin's price fluctuations:
<ul>
<li>Shallow order books: Altcoins frequently drop on mid-sized Bitcoin moves due to limited depth in their markets.</li>
<li>Liquidity challenges: Automated Market Maker (AMM)-based tokens often <a href="https://x.com/krugermacro/status/1876880103663177907">have</a> market cap-to-liquidity ratios ranging from 10:1 to 30:1, further amplifying volatility.</li>
</ul>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42871814/bitcoin-slides-5-touches-95000-mark-why-is-btc-going-down">Bitcoin Slides 5%, Touches $95,000 Mark: Why Is BTC Going Down?</a>
What's Next: Krüger's analysis underscores the importance of adapting trading strategies:
<ul>
<li>He predicts that fewer rate cuts could either signal a stronger-than-expected economy or a cautious monetary policy stance, requiring traders to remain nimble.</li>
<li>Investors should prepare for continued shifts in macroeconomic projections and remain informed to capitalize on opportunities in an evolving market landscape.</li>
</ul>
Read Next: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42874069/bitcoin-could-drop-as-low-as-75000-if-it-fills-this-liquidity-gap-expert-warns">Bitcoin Could Drop As Low As $75,000 If It Fills This Liquidity Gap, Expert Warns</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin Is Suffering From A Shift In Macro Expectations, Analyst Says: Here's What That Means

Friday&#8217;s official jobs report is expected to shed light on the cooling U.S. labor market in December 2024, as economists project slower hiring that could ease pressure on the Federal Reserve amid renewed inflation concerns and policy uncertainty under <a href="https://www.benzinga.com/topic/donald-trump">Donald Trump</a><a href="https://www.benzinga.com/topic/donald-trump">&#8216;s incoming administration.</a>
In a preview shared Wednesday, ADP's National Employment Report—a private-sector-focused indicator—revealed that employers added 122,000 jobs in December, marking a drop from November&#8217;s 146,000 and <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42873182/us-private-businesses-add-122000-jobs-in-december-the-labor-market-downshifted-to-a-more-modest-pace-of-growth">coming in below expectations. </a>
Nela Richardson, ADP's chief economist, said: &#8220;The labor market downshifted to a more modest pace of growth in the final month of 2024, with a slowdown in both hiring and pay gains. Health care stood out, creating more jobs than any other sector.&#8221;
<h3 class="wp-block-heading">What To Expect: Nonfarm Payrolls, Unemployment, Wages</h3>
The consensus among economists – as tracked by TradingEconomics – is that nonfarm payrolls will show a net gain of 154,000 jobs in December, down sharply from the 227,000 added in November. 
Such a slowdown would reflect a labor market losing steam, as monthly payroll growth has averaged 140,000 over the past six months, compared to 220,000 earlier in 2024.
The unemployment rate is forecast to remain unchanged at 4.2%, while average hourly earnings are expected to rise 0.3% month-over-month, a deceleration from the 0.4% growth seen in November. 
On a yearly basis, wage growth is projected to hold at 4%, a sign that wage pressures are cooling after months of post-pandemic labor shortages.
<h3 class="wp-block-heading">Implications For Markets And The Fed</h3>
A weaker-than-expected jobs report on Friday could bolster U.S. stocks, weaken the dollar, and lower government bond yields, as investors may interpret it as a signal that the Fed has room to ease monetary policy further. 
On the flip side, stronger-than-expected job creation or lower unemployment could spur fears of a resilient labor market, which might delay the Fed&#8217;s easing timeline.
Wells Fargo analysts said they anticipate a return to trend-like payroll growth in December, highlighting that worker participation has softened slightly, with prime-age participation leveling off—a further indication of cooling labor demand.
Bank of America projects a 175,000 increase in December payrolls, slightly above consensus. Yet, economists at the investment bank indicate the jobs market is "normalizing," with moderating wage growth and low jobless claims suggesting an orderly slowdown.
&#8220;Our base case is that further modest labor market weakness will push the Fed to cut twice more, in March and June,&#8221; Bank of America&#8217;s economist Stephen Juneau said in a note. 
Uncertainty over the Federal Reserve&#8217;s policy path in 2025 remains elevated, with markets pricing in just 40 basis points of cumulative rate cuts by year-end—equivalent to only one fully priced interest rate reduction.
The stakes are high, as Treasury yields have recently surged to their highest levels in over a year, with the 30-year yield approaching the critical 5% threshold. All eyes now turn to Friday&#8217;s jobs report, set for release at 8:30 a.m. ET.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42878896/dollar-jumps-to-14-month-highs-30-year-yields-near-danger-zone-as-trump-mulls-national-economic-emergency-to-set-tariffs">Dollar Hits 14-Month High, 30-Year Yields Near Critical Threshold As Trump Reportedly Mulls Economic Emergency Tariffs</a></li>
</ul>
Photo: Shutterstock

Bonds

Treasuries

Econ #s

Is Labor Market Cooling Or Raising Fed Concerns? What To Watch In Friday's Jobs Report

BTIG analyst Gray Powell downgrades Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) from Buy to Neutral.

Downgrades

PANW

BTIG Downgrades Palo Alto Networks to Neutral

BTIG analyst Marie Thibault downgrades Inari Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NARI#NASDAQ">NARI</a>) from Buy to Neutral.

NARI

BTIG Downgrades Inari Medical to Neutral

NTES

NetEase shares are trading higher after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $90 to $108.

Arthur J. Gallagher shares are trading higher after Piper Sandler upgraded the stock from Neutral to Overweight and raised its price target from $285 to $315.

USA Natural Gas Storage -40B Vs -39B Est.; -116B Prior

Benchmark analyst Mike Hickey initiates coverage on Gambling.com Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAMB#NASDAQ">GAMB</a>) with a Buy rating and announces Price Target of $16.

GAMB

Benchmark Initiates Coverage On Gambling.com Gr with Buy Rating, Announces Price Target of $16

Can you feed two people on just $300 a month for groceries? One Reddit user <a href="https://www.reddit.com/r/budget/comments/1b4tay9/how_would_a_couple_get_away_with_only_spending/">asked</a> this question and the answers flooded in from people all over the country. The responses were mixed, but most agreed on one key takeaway – it's tough without some serious trade-offs.
Most agree that spending only $300 monthly for two people is possible, but it's a big challenge. You'd have to focus on cheap foods like rice, beans, pasta and potatoes to make it work. You'd also need to buy in bulk and cook everything from scratch. However, this means giving up convenience and variety, which some people feel isn't worth it.
Don't Miss:
<ul>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>
<h2 class="wp-block-heading">What Works for Some</h2>
Many people suggested buying in bulk to save money. For example, buying meat when it's on sale and freezing it can stretch your budget. Staples like rice, beans and pasta are also key because they can make many meals and cost little, making them essential for budget-conscious grocery shopping.
Shopping strategically also plays a big role in keeping costs low. Discount stores like Aldi and Costco were <a href="https://www.benzinga.com/money/benefits-of-saving-money">popular choices for saving money</a>. People also recommended buying fruits and vegetables in season and looking for items on sale.
Cooking at home is a must if you want to stick to a low budget. Many said that making things like bread or soups from scratch greatly helps. Some also mentioned using spices and sauces to make simple meals taste better.
See Also: The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?
Another way to save is to cut out extras like snacks, sugary drinks and alcohol. Sticking to water, tea or coffee can keep drink costs low while giving you options. Someone said, &#8220;I see people check out carts full of beverages. It's amazing how much people spend on soda and beer.&#8221;
While $300 is possible, most people agree it's not easy. Keeping grocery costs that low <a href="https://www.benzinga.com/money/how-much-should-i-spend-on-groceries">takes a lot of time and effort</a>. You must shop for the best deals, plan meals carefully and cook almost everything yourself. Some worry that eating so cheaply might mean missing out on important nutrients or eating lower-quality food. Others said sticking to this budget could get boring because of less variety.
<h2 class="wp-block-heading">Real-Life Numbers</h2>
Several users shared their actual grocery budgets to provide context. A family of two in California sticks to $250 by relying on bulk items, discount stores and a chest freezer. Curiously, they said, &#8220;We don&#8217;t drink milk because we don&#8217;t like it, so our drink is mostly water and tea. We don&#8217;t even buy water like most Americans. The fridge filters our water well enough.&#8221;
Trending: If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?
Meanwhile, one couple in North Carolina spends about $500 per month and cannot imagine going lower without eating mostly rice and beans. In a high-cost-of-living area, one Redditor manages $360 for a family of four by shopping sales and using coupons. &#8220;I grocery shop like it's a competition. I search for coupons for things I want; then, I clip coupons for things I wouldn't normally get if it's a good enough deal and I can make more than one meal with it,&#8221; they said.
If you're aiming for a $300 <a href="https://www.benzinga.com/money/how-much-should-i-spend-on-groceries">grocery budget</a>, it's possible – but it's not easy. Most people agree that unless you're okay with a <a href="https://www.benzinga.com/24/12/42531924/elon-musk-had-a-food-budget-of-30-a-month-his-diet-was-mostly-hot-dogs-and-oranges-in-america-its-pretty-easy-to-keep-yourself-alive">basic diet</a>, you'll need to spend more to maintain variety, quality and convenience.
It's about finding balance. If saving money is your top priority, you must make sacrifices. But if you value a broader, healthier diet, spending a little more is okay. After all, food isn't just a line item in the budget – it's a major part of life.
Read Next:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li>Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
</ul>

Personal Finance

A Couple Asks: Can You Get Away With Spending Only $300 Per Month On Groceries? Here's What People Said – Most Agreed On This One Thing

While shares of <a>Arthur J. Gallagher </a>&amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) have declined following the purchase of AssuredPartners, this acquisition is likely to be accretive to earnings from 2025, according to Piper Sandler.
The Arthur J. Gallagher Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58b05504b85e93000174c0f8/paul-newsome">Analyst </a><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58b05504b85e93000174c0f8/paul-newsome">Paul Newsome</a> upgraded the rating for Arthur J. Gallagher from Neutral to Overweight, while raising the price target from $285 to $315. 
The Arthur J. Gallagher Thesis: Following the pullback in the stock, it is currently trading "closer to peers than it has in recent history," Newsome said in the upgrade note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
The stock valuation is attractive, since Arthur J. Gallagher's stock "typically trades at a premium to peers due to higher organic growth," the analyst stated. "We estimate organic growth for AJG will be about 7.2% in 2025," he added.
AssuredPartners is "strategically good" for Arthur J. Gallagher and synergies from the acquisition are likely to be "1.4% accretive to adjusted EPS in 2025 and 8.1% accretive to adjusted EPS in 2026," Newsome further wrote.
AJG Price Action: Shares of Arthur J. Gallagher had risen by 2.18% to $285.90 at the time of publication on Wednesday.
Read More: • <a href="https://www.benzinga.com/general/market-summary/24/12/42548385/fund-managers-increase-allocation-to-banking-and-insurance-stocks-in-december-here-are-the-best-performing-financial-stocks-in-2024">Fund Managers Increase Allocation To Banking And Insurance Stocks In December: Here Are The Best Performing Financial Stocks In 2024</a>
Photo: Shutterstock

Analyst Color

Upgrades

Insurance

Arthur J. Gallagher To Benefit From AssuredPartners Acquisition In 2025, Says Bullish Analyst

BHAT

Blue Hat Interactive shares are trading lower. The company announced a registered direct offering of 55.95 million shares.

Benchmark analyst Michael Ward initiates coverage on Lithia Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAD#NYSE">LAD</a>) with a Buy rating and announces Price Target of $400.

Benchmark Initiates Coverage On Lithia Motors with Buy Rating, Announces Price Target of $400

BofA raised the firm's price target on Tempus AI (TEM) to $54 from $52 and keeps a Neutral rating on the shares. The Life Sciences Tools sector und...

Tempus AI price target raised to $54 from $52 at BofA

20:10 EST Cathie Wood's ARK Investment bought 317.6K shares of Tempus AI (TEM) today Published first on TheFly – the ultimate source for real-time,...

Cathie Wood's ARK Investment bought 317.6K shares of Tempus AI today

Tempus AI: Recent Weakness Presents Gift Ahead Of The Holidays

20:04 EST Cathie Wood's ARK Investment bought 335.7K shares of Tempus AI (TEM) today Published first on TheFly – the ultimate source for real-time,...

Cathie Wood's ARK Investment bought 335.7K shares of Tempus AI today

20:02 EST Cathie Wood's ARK Investment bought 348K shares of Tempus AI (TEM) today Published first on TheFly – the ultimate source for real-time, m...

Cathie Wood's ARK Investment bought 348K shares of Tempus AI today

Bullish option flow detected in tempus AI (TEM) Inc Class A with 4,392 calls trading, 1.9x expected, and implied vol increasing almost 2 points to ...

tempus AI Inc Class A call volume above normal and directionally bullish

FDA proposes asbestos-testing standards for talc products (update)

Bullish option flow detected in tempus AI (TEM) Inc Class A with 4,241 calls trading, 2.0x expected, and implied vol increasing almost 3 points to ...

The FDA has issued draft guidance to provides recommendations to sponsors and other interested parties on the use of artificial intelligence to pro...

Tempus AI up after FDA issues draft guidance on AI use in drug decision making

Tempus AI (TEM), announced a collaboration with Genialis, the RNA-biomarker company. The multi-year agreement allows Genialis to leverage Tempus' m...

Tempus AI teams with Genialis to develop RNA-based biomarker algorithms

COTY

KVUE

LRLCF

Press Releases

Tempus to Participate in the Piper Sandler 36th Annual Healthcare Conference

Artificial Intelligence (AI) Redefining Medical Diagnostics Industry That's Expected to be a $7.2 Billion Market by 2029

Small Cap

Opinion

Healthcare Executives Embrace Generative AI to Boost Patient Outcomes

Personalis and Tempus Expand Collaboration to Biopharma

New CMS Decision Provides Medicare Coverage for the Clinical Use of the Tempus ECG-AF Device

Why Healthcare Providers Are Increasingly Trusting Artificial Intelligence for Detection & Diagnosis

Tempus Now an In-Network Provider for Blue Cross Blue Shield Illinois, Blue Shield California, and Avalon Healthcare Solutions

Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses

Tempus to Present at 43rd Annual J.P. Morgan Healthcare Conference

Tempus Announces a Collaboration With Genialis to Develop RNA-Based Biomarker Algorithms

AMZN

AVAI

CKPT

CRDF

ISRG

NVDA

ONCY

PEGA

PSNL

RHHBY

RXRX

TSX:ONC

Agilent Technologies

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Avantor

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

BioLife Solns

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Danaher

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

Tempus AI

Intérêt court

Tempus AI (NASDAQ:TEM) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL